Matthew Gallagher to Anxiety Disorders
This is a "connection" page, showing publications Matthew Gallagher has written about Anxiety Disorders.
Connection Strength
4.818
-
Zemestani M, Ommati P, Rezaei F, Gallagher MW. Changes in neuroticism-related constructs over the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in patients on an optimal dose of SSRI. Personal Disord. 2022 03; 13(2):171-181.
Score: 0.599
-
Lang AJ, Gallagher MW. BRAT special issue editorial. Behav Res Ther. 2020 04; 127:103590.
Score: 0.558
-
Gallagher MW, Phillips CA, D'Souza J, Richardson A, Long LJ, Boswell JF, Farchione TJ, Barlow DH. Trajectories of change in well-being during cognitive behavioral therapies for anxiety disorders: Quantifying the impact and covariation with improvements in anxiety. Psychotherapy (Chic). 2020 09; 57(3):379-390.
Score: 0.556
-
Gallagher MW, Long LJ, Richardson A, D'Souza J, Boswell JF, Farchione TJ, Barlow DH. Examining Hope as a Transdiagnostic Mechanism of Change Across Anxiety Disorders and CBT Treatment Protocols. Behav Ther. 2020 01; 51(1):190-202.
Score: 0.532
-
Buckner JD, Walukevich KA, Zvolensky MJ, Gallagher MW. Emotion regulation and coping motives serially affect cannabis cessation problems among dually diagnosed outpatients. Psychol Addict Behav. 2017 Nov; 31(7):839-845.
Score: 0.470
-
Buckner JD, Zvolensky MJ, Ecker AH, Jeffries ER, Lemke AW, Dean KE, Businelle MS, Gallagher MW. Anxiety and cannabis-related problem severity among dually diagnosed outpatients: The impact of false safety behaviors. Addict Behav. 2017 07; 70:49-53.
Score: 0.452
-
Zemestani M, Ezzati S, Nasiri F, Gallagher MW, Barlow DH, Kendall PC. A culturally adapted unified protocol for transdiagnostic treatment of anxiety disorders in adolescents (UP-A): a randomized waitlist-controlled trial. Psychol Med. 2024 Jan; 54(2):385-398.
Score: 0.177
-
Zemestani M, Davoudi F, Farhadi A, Gallagher MW. A preliminary examination of unified protocol for transdiagnostic treatment of emotional disorders in patients with panic disorder: a single-case experimental design in Iran. Anxiety Stress Coping. 2022 11; 35(6):701-718.
Score: 0.156
-
Farchione TJ, Fitzgerald HE, Curreri A, Janes AC, Gallagher MW, Sbi S, Eustis EH, Barlow DH. Efficacy of the Unified Protocol for the treatment of comorbid alcohol use and anxiety disorders: Study protocol and methods. Contemp Clin Trials. 2021 09; 108:106512.
Score: 0.154
-
O'Donnell ML, Lau W, Chisholm K, Agathos J, Little J, Terhaag S, Brand R, Putica A, Holmes ACN, Katona L, Felmingham KL, Murray K, Hosseiny F, Gallagher MW. A Pilot Study of the Efficacy of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Treating Posttraumatic Psychopathology: A Randomized Controlled Trial. J Trauma Stress. 2021 06; 34(3):563-574.
Score: 0.149
-
Eustis EH, Gallagher MW, Tirpak JW, Nauphal M, Farchione TJ, Barlow DH. The Unified Protocol compared with diagnosis-specific protocols for anxiety disorders: 12-month follow-up from a randomized clinical trial. Gen Hosp Psychiatry. 2020 Nov - Dec; 67:58-61.
Score: 0.145
-
Barlow DH, Gallagher MW, Farchione TJ. Equivalence? Clarifications Required-Reply. JAMA Psychiatry. 2018 01 01; 75(1):103-104.
Score: 0.120
-
Carl JR, Gallagher MW, Barlow DH. Development and Preliminary Evaluation of a Positive Emotion Regulation Augmentation Module for Anxiety and Depression. Behav Ther. 2018 11; 49(6):939-950.
Score: 0.120
-
Barlow DH, Farchione TJ, Bullis JR, Gallagher MW, Murray-Latin H, Sauer-Zavala S, Bentley KH, Thompson-Hollands J, Conklin LR, Boswell JF, Ametaj A, Carl JR, Boettcher HT, Cassiello-Robbins C. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders: A Randomized Clinical Trial. JAMA Psychiatry. 2017 09 01; 74(9):875-884.
Score: 0.118
-
Boswell JF, Iles BR, Gallagher MW, Farchione TJ. Behavioral activation strategies in cognitive-behavioral therapy for anxiety disorders. Psychotherapy (Chic). 2017 Sep; 54(3):231-236.
Score: 0.118
-
Brake CA, Sauer-Zavala S, Boswell JF, Gallagher MW, Farchione TJ, Barlow DH. Mindfulness-Based Exposure Strategies as a Transdiagnostic Mechanism of Change: An Exploratory Alternating Treatment Design. Behav Ther. 2016 Mar; 47(2):225-38.
Score: 0.104
-
Carl JR, Gallagher MW, Sauer-Zavala SE, Bentley KH, Barlow DH. A preliminary investigation of the effects of the unified protocol on temperament. Compr Psychiatry. 2014 Aug; 55(6):1426-34.
Score: 0.093
-
Boswell JF, Sauer-Zavala SE, Gallagher MW, Delgado NK, Barlow DH. Readiness to change as a moderator of outcome in transdiagnostic treatment. Psychother Res. 2012; 22(5):570-8.
Score: 0.082
-
Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Thompson-Hollands J, Carl JR, Gallagher MW, Barlow DH. Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behav Ther. 2012 Sep; 43(3):666-78.
Score: 0.080
-
Bentley KH, Cohen ZD, Kim T, Bullis JR, Nauphal M, Cassiello-Robbins C, Sauer-Zavala S, Sbi S, Gallagher MW, Farchione TJ, Barlow DH. The Nature, Timing, and Symptom Trajectories of Dropout From Transdiagnostic and Single-Diagnosis Cognitive-Behavioral Therapy for Anxiety Disorders. Behav Ther. 2021 11; 52(6):1364-1376.
Score: 0.038